Clinical trial
Markers and Mechanisms of Vascular Disease in Type II Diabetes
NCT00256646 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00256646 |
|---|---|
| Title | Markers and Mechanisms of Vascular Disease in Type II Diabetes |
| Official title | CSP #465D - Markers And Mechanisms of Vascular Disease in Type II Diabetes |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Collaborators | American Diabetes Association |
| Status | Completed |
| Study type | Observational |
| Conditions | Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Rosiglitazone |
| Enrollment | 298 |
| Start date | Jun 1, 2007 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Nov 21, 2005 |
| Last update posted | May 23, 2014 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: